קסנאגיס 1 מג Israel - hebreo - Ministry of Health

קסנאגיס 1 מג

padagis israel pharmaceuticals ltd, israel - alprazolam - טבליה - alprazolam 1 mg - alprazolam - alprazolam - treatment of anxiety accompanied by depression. treatment of panic states with or without accompanying phobia.

קסנאגיס 0.25 מג Israel - hebreo - Ministry of Health

קסנאגיס 0.25 מג

padagis israel pharmaceuticals ltd, israel - alprazolam - טבליה - alprazolam 0.25 mg - alprazolam - alprazolam - treatment of anxiety accompanied by depression. treatment of panic states with or without accompanying phobia.

פבוקסיל 100 Israel - hebreo - Ministry of Health

פבוקסיל 100

padagis israel pharmaceuticals ltd, israel - fluvoxamine maleate - טבליה - fluvoxamine maleate 100 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

פבוקסיל 50 Israel - hebreo - Ministry of Health

פבוקסיל 50

padagis israel pharmaceuticals ltd, israel - fluvoxamine maleate - טבליה - fluvoxamine maleate 50 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

אגיסרק 16 Israel - hebreo - Ministry of Health

אגיסרק 16

padagis israel pharmaceuticals ltd, israel - betahistine dihydrochloride - טבליה - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

אלגרו תרסיס לאף Israel - hebreo - Ministry of Health

אלגרו תרסיס לאף

trima israel pharmaceutical products maabarot ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 %w/w - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hay fever and perenial rhinitis.

תיאותרים 100 Israel - hebreo - Ministry of Health

תיאותרים 100

trima israel pharmaceutical products maabarot ltd - theophylline anhydrous - טבליות בשחרור איטי - theophylline anhydrous 100 mg - theophylline - theophylline - long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema

תיאותרים 200 Israel - hebreo - Ministry of Health

תיאותרים 200

trima israel pharmaceutical products maabarot ltd - theophylline anhydrous - טבליות בשחרור איטי - theophylline anhydrous 200 mg - theophylline - theophylline - long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema

תיאותרים 300 Israel - hebreo - Ministry of Health

תיאותרים 300

trima israel pharmaceutical products maabarot ltd - theophylline anhydrous - טבליות בשחרור איטי - theophylline anhydrous 300 mg - theophylline - theophylline - long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema

מונטלוקאסט - תרימה 4 מג Israel - hebreo - Ministry of Health

מונטלוקאסט - תרימה 4 מג

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליות לעיסות - montelukast as sodium salt 4 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.